Y-90
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Y-90, covering 2022-12-06 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC [Phase 2]